Abstract
Gene expression is controlled at several steps. Transcription is one of the important steps at which regulation occurs. Tumor suppressors such as p53, which are basically transcription factors, carry out their function primarily by the transcriptional activation of the target genes. The promoter region of a gene plays a major role in its transcriptional regulation, so it would be very useful for laboratories involved in the study of the tumor suppressor function to know the techniques used to analyze the regulation of gene promoters, particularly if they encode transcription factors.
Keywords
- Reporter Protein
- Chloramphenicol Acetyl Transferase
- Chloramphenicol Acetyl Transferase Activity
- Charge Plasma Membrane
- Luciferase Assay Reagent
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Thompson, J. F., Hayes, L. S., and Lloyd, D. B (1993) Modulation of firefly luciferase stability and impact on studies of gene regulation. Gene 103, 171–177.
De Wet, J. R., Wood, K. V., DeLuca, M., Helinski, D. R., and Subramani, S. (1987) Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7, 725–737.
Bronstein, I., Fortin, J., Stanley, P. E.,. Stewart, G. S., and Kricka, L. J. (1994) Chemiluminescent and bioluminescent reporter gene assays. Anal. Biochem. 219, 169–181.
Miller, J. (1972) Experiments in Molecular Genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Young, D. C, Kingsley, S. D., Ryan, K. A., and Dutko F. J.(1993) Selective inactivation of eukaryotic B-galactosidase in assays for inhibitors of HIV-1 TAT using bacterial B-galactosidase as a reporter enzyme. Anal. Biochem. 215, 24–30.
Jain, V and Magrath, I. (1991) A chemiluminescent assay for quantitation of β-galactosidase in the femtogram range: application to quantitation of β-galactosidase in lacZ transfected cells. Anal. Biochem. 199, 119–124.
Berger, J., Hauber, J., Hauber, R., Geiger, R, and Cullen B. R. (1988) Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 66, 1–10.
Selden, R. F., Howie, K. B., Rowe, M. E., Goodman, H. M., and Moore, D. D. (1986) Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Mol. Cell. Biol. 6, 3173–3179.
Inouye, S. and Tsuji, F. I. (1994) Aequorea green fluorescent protein: expression of the gene and fluorescence characteristics of the recombinant protein. FEBS Lett. 341, 277–280.
Gorman, C. M., Moffat, L. F., and Howard B. H.(1982) Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell Biol. 2, 1044–1051.
Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72, 248–254.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265–275.
Laiminis, L. A., Gruss, P., Pozzatti, R, and Khoury, G. (1984) Characterization of enhancer elements in the long terminal repeat of Moloney murine sarcoma virus. J. Virol. 49, 183–189.
Gilman, M. Z., Wilson, R. N, and Weinberg, R. A (1986) Multiple protein binding sites in 5′-flanking region regulate c-fos expression. Mol. Cell. Biol. 6, 4305–4316.
Nordeen, S. K. (1988) Luciferase reporter gene vector for analysis of promoters and enhancers. Biotechniques 6, 454–457.
Luckow, B. and Schütz, G. (1987) CAT constructions with multiple unique sites for functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15, 5490.
Vaheri, A. and Pagano, J. S. (1965) Infectious poliovirus RNA: a sensitive method of assay. Virology 27, 434–436.
Graham, F. L. and van der Eb, A. J. (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456–467.
Felgner, P. L., Gadek, T. R., Holm, M., et al. (1987) Lipofectin: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci USA 84, 7413–7417.
Sambrook, J., Fritsch E. F., and Maniatis, T. (eds.) (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Ausubel, F. M., Brent, R., Kingston, R. E., et al. (eds.) (1994) Current Protocols in Molecular Biology. Wiley, New York.
El-Deiry, W S., Tokino, T, Velculescu, V E., et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817–825.
El-Diery, W S., Tokino, T, Waldman, T, et al. (1995) Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res. 55, 2910–2919.
Hollander, M. C, Alamo, I., Jackman, J., Wang, M. G., McBride, O. W and Fornace, A. C, Jr. (1993) Analysis of the mammalian gadd45 gene and its response to DNA damage. J. Biol. Chem. 268, 24385–24393.
Miyashita, T. and Reed J. C. (1995) Tumor suppressor p53 is a direct transcriptional activator of human bax gene. Cell 80, 293–299.
Seol, D., Chen, Q., Smith, M. L., and Zarnegar, R. (1999) Regulation of the c-met proto-oncogene promoter by p53. J. Biol. Chem. 274, 3565–3572.
Morris, G. F., Bischoff, J. R., and Mathews, M. B. (1996) Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53. Proc. Natl. Acad. Sci. USA 93, 895–899.
Buckbinder, L., Talbott, R., Velasco-Miguel, S., et al. (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377, 646–649.
Takimoto, R. and El-Deiry, W. S. (2000) Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site. Oncogene 19, 1735–1743.
Chin, Y. E., Kitagawa, M., Su, W. C., You, Z. H., Iwamoto, Y., and and Fu, X. Y. (1996) Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 272, 719–722.
Zeng, Y. X., Somasundaram, K., and El-Diery, W. S.(1997) AP2 inhibits cancer growth and activates p21WAF1/CIP1 expression. Nat. Genet. 15, 78–82.
Kardassis, D., Papakosta, P., Pardali, K., and Moustakas, A. (1999) c-Jun transactivates the promoter of the human p21WAF1/Cip1 gene by acting as a superactivator of the ubiquitous transcription factor Sp1. J. Biol. Chem. 274, 29572–29581.
Moustakas, A. and Kardassis, D. (1998) Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc. Natl. Acad. Sci. USA 95, 6733–6738.
Somasundaram, K., Zhang, H., Zeng, Y., et al. (1997) Arrest of the cell cycle by the tumor suppressor BRCA1 requires the CDK-inhibitor p21WAF1/Cip1. Nature 389, 187–190.
Datto, M. B., Yu, Y., and Wang, X. (1995) Fuctional analysis of the transforming growth factor β responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem. 270, 28623–28628.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Somasundaram, K., Das, S., Lakhotia, S., Wajapeyee, N. (2003). Analysis of Gene Promoter Regulation by Tumor Suppressor Genes. In: El-Deiry, W.S. (eds) Tumor Suppressor Genes. Methods in Molecular Biology™, vol 223. Humana Press. https://doi.org/10.1385/1-59259-329-1:101
Download citation
DOI: https://doi.org/10.1385/1-59259-329-1:101
Publisher Name: Humana Press
Print ISBN: 978-0-89603-987-2
Online ISBN: 978-1-59259-329-3
eBook Packages: Springer Protocols